JILIN PROVINCE HUINAN CHANGLONG BIO-PHARMACY CO. LTD. financial statements, including revenue, expenses, profit, and loss
The total revenue of JIL for the last semiannual is 55.88 M EUR, and it's 6.78% higher compared to the previous semiannual. The net income of H2 23 is 8.44 M EUR.